Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore

• Status: Withdrawn
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk for severe COVID19 illness.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Hydroxychloroquine

Criteria

Inclusion Criteria:

• Symptomatic with COVID illness (either RT-PCR test confirmed or highly suspect clinical symptoms)

• Call into office within the first 7 days of illness

• Have any of the following high risk conditions:

• Age >60

• HTN, CAD, or chronic heart disease

• Diabetes

• Chronic kidney disease

• Chronic lung disease

• Active or recent chemotherapy for malignancy

• Organ transplant

• Taking Immune-suppressing medications

• HIV with CD4 <200 cells/mm3

• Experiencing at least one of the following high risk symptoms:

• Severe cough

• Fever 100.0F or greater

• Diarrhea

• Shortness of Breath

• Hypoxia

Exclusion Criteria:

• HCW not meeting high-risk criteria or those with a contraindication to HCQ will not be offered HCQ